chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sensitive to touch; itchy sensation if touched; Redness on arm; arm sore; This spontaneous case was reported by a consumer and describes the occurrence of SENSITIVE SKIN (sensitive to touch), PRURITUS (itchy sensation if touched), VACCINATION SITE ERYTHEMA (Redness on arm) and VACCINATION SITE PAIN (arm sore) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SENSITIVE SKIN (sensitive to touch), PRURITUS (itchy sensation if touched), VACCINATION SITE ERYTHEMA (Redness on arm) and VACCINATION SITE PAIN (arm sore). At the time of the report, SENSITIVE SKIN (sensitive to touch), PRURITUS (itchy sensation if touched) and VACCINATION SITE ERYTHEMA (Redness on arm) outcome was unknown and VACCINATION SITE PAIN (arm sore) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details were reported. No treatment medication details were reported.
Client registered with false DOB, 11/16/2004, showing that they were 16 years old and eligible for Pfizer vaccine. Vaccine was given due to state data entry software system inability to cross check with DOB of the client in the state immunization registry before entering. No known adverse events. DOB updated in data entry software system to show client is in fact 10 years old, client removed from site's invitation list, and message left for parent.
Fever 102.7 so gave baby 100mg Motrin.  Not 2 minutes later he began seizing, eyes rolling back and lips turning blue.  Continued for a period of 2-4 minutes.  EMS was called and was transported to nearest hospital.  We controlled his temperature and he was back to baseline within 24 hours.  No signs of infection on CBC.
Dizziness; Fatigue; Body aches; Swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER0169) via an unspecified route of administration in the left arm on 13Apr2021 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not receive any concomitant medications. The patient had no known allergies to medications, food, or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8731) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05May2021 at 07:00, the patient experienced dizziness, fatigue, body aches and swollen lymph nodes. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events dizziness, fatigue, body aches and swollen lymph nodes were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
ankle is very swollen; Chills; a nagging headache for several days; upper arm is swollen; hard, there is a red spot at the injection site and that there is a reddish brown circle the size of a quarter around the injection site; hot to touch, itchy hard; injection site is swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot to touch, itchy hard), JOINT SWELLING (ankle is very swollen), PERIPHERAL SWELLING (upper arm is swollen), VACCINATION SITE DISCOLOURATION (reddish brown circle the size of a quarter around the injection site) and VACCINATION SITE INDURATION (hard, there is a red spot at the injection site and that there is a reddish brown circle the size of a quarter around the injection site) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported.     On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (hot to touch, itchy hard), JOINT SWELLING (ankle is very swollen), PERIPHERAL SWELLING (upper arm is swollen), VACCINATION SITE DISCOLOURATION (reddish brown circle the size of a quarter around the injection site), VACCINATION SITE INDURATION (hard, there is a red spot at the injection site and that there is a reddish brown circle the size of a quarter around the injection site), VACCINATION SITE PRURITUS (hot to touch, itchy hard), VACCINATION SITE SWELLING (injection site is swollen), CHILLS (chills) and HEADACHE (a nagging headache for several days). The patient was treated with CORTISONE at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (hot to touch, itchy hard), JOINT SWELLING (ankle is very swollen), PERIPHERAL SWELLING (upper arm is swollen), VACCINATION SITE DISCOLOURATION (reddish brown circle the size of a quarter around the injection site), VACCINATION SITE INDURATION (hard, there is a red spot at the injection site and that there is a reddish brown circle the size of a quarter around the injection site), VACCINATION SITE PRURITUS (hot to touch, itchy hard), VACCINATION SITE SWELLING (injection site is swollen) and HEADACHE (a nagging headache for several days) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, Body temperature: 96.4 (Low) Patient reported that her temperature was normally 97.7 but it was around 96.4 for several days after the vaccination..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Patient was receiving Moderna as a booster to the Janssen injection he had received on 6/7/21.  There was a miscommunication between the provider and the MA and the MA administered 100mcg (0.5 cc) to the patient instead of the 50mcg (0.25 cc).  Patient was informed and reported no ill effects
PER PT, they have a bruised muscle due to the covid19 vaccine. they've visited the dr numerous times and the md has confirmed that it is bruised. ever since the shot, pt cannot lift or move arm like before and is in pain.
got the 1st dose of the vaccine and tested positive from covid-19; got the 1st dose of the vaccine and tested positive from covid-19; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program.  A female patient of unspecified age received BNT162B2 first dose on unspecified date at single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Patient wanted to know how long does a person have to wait to get the 2nd dose of the Comirnaty vaccine if they tested positive for Covid after getting the 1st dose, if its 90 days or 6 months. The outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Pain in Injection arm site also red, swollen and itchy.    Pain went to underarm.
My menstrual cycle became very heavy and in turn caused me to lose enough blood to severely deplete my iron.  I was sent to the Hematology center to get 8 bags of iron over a 4 month period.  I also had an IUD inserted to keep from having a period monthly.
Night of vaccines, sites started itching, rash on arms, chest, face. Painful and itchy. No fever.
?COVID Arm? at injection site. Red, swollen, itchy.  About 1 in wide, 2 inches long.
Right knee joint pain began 20-24 hours after vaccine and is persisting today, 2 days after vaccination. Pain is present in right knee joint while walking or standing. Pain slightly eases with ibuprofen but not totally.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a female patient who received SHINGRIX for prophylaxis. Previously administered products included DPT with an associated reaction of urticaria (received in 2000, see case US2018GSK115151) and Influenza vaccine with an associated reaction of urticaria (received in 2000, see case US2018GSK115151). On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain, injection site swelling and activities of daily living impaired. On an unknown date, the outcome of the injection site pain, injection site swelling and activities of daily living impaired were unknown.  It was unknown if the reporter considered the injection site pain, injection site swelling and activities of daily living impaired to be related to SHINGRIX. Additional details were provided as follows: The patient declined to provide date of birth. The age at vaccination was not reported. The patient reported that they experienced a painful area at the injection site, and swelling, further described as a deep arm pain, after receiving SHINGRIX. The patient reported that they could not do a lot for a few days. This case was linked with US2018GSK115151, US2018109095 and US2018109097 reported by the same reporter.
After 4 hours of receiving the vaccine, I developed pain to vaccine site, chills, burning to both eyes, and weakness to bilateral legs when cold hit my feet. This lasted about 30hrs and was relieved by 2 doses of dayquil.
Patient report to have developed red blotches all over both lower extremities a few weeks after receiving first covid vaccine. Leg began to swell with bleeding and open sores. Required hospitalization 4/22/21.
Pain to that area when lifting arm; panic attack; tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 27Jan2021 (Lot number: EL1283) at the age of 59 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "Panic disorder" (unspecified if ongoing); "Tongue cancer" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, Name of product: Pfizer BNT162B2, Reason for taking: Prevent Covid-19, Date started: 05Jan2021, Lot/Batch no: EH9899, Anatomical site: Upper right arm), administration date: 05Jan2021, for COVID-19 immunization, reaction(s): "Pain to that area when lifting arm". The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 27Jan2021, outcome "recovered" (2021), described as "Pain to that area when lifting arm"; PANIC ATTACK (non-serious) with onset 27Jan2021, outcome "recovered" (2021), described as "panic attack"; FATIGUE (non-serious) with onset 27Jan2021, outcome "recovered" (2021), described as "tired". Therapeutic measures were not taken as a result of pain in extremity, panic attack, fatigue.  Additional information: No surgical treatment needed for the event. No other product was taken together with those indicated.  No follow-up attempts are possible. No further information is expected.
Patient is a 28 year old male generally healthy,who presented to ER with complaints of lightheadedness,near syncope and hives after Moderna booster 12/27/2021   Previous 2 vaccinations have been Pfizer.  Patient woke up at 3 AM secondary to pruritis and noted whole body hives,no oral lesions. He felt hot,did not check his temp. He felt that he will pass out.    Patient took Benadryl 50 mg orally at about 5 AM today prior to presentation..   He complaints of nausea, mild shortness of breath.  No vomiting.  No diarrhea.   No chest pain or abdominal pain. Per patient he had similar reaction to unknown meds 3 years ago -treated at MGH.     ED COURSE: On arrival patient medicated with Benadryl 50 mg IV, Decadron 10 mg IV, famotidine, epinephrine IM x1   Recheck at 1310 hrs.: Urticaria resolved, patient feeling better, ambulatory without dizziness.   Recheck at 1400 hrs.: Diffuse urticaria, patient reports tight sensation in throat and mid epigastric area. Voice normal.  No respiratory distress.  Will premedicate with additional epinephrine and add hydroxyzine.
DYSTONIC REACTION INVOLVING NECK AND LEFT ARM (SAME SIDE AS INJECTION SITE)
Information has been received from a consumer concerning her 77 year old husband with normal pressure hydrocephalus and a lumboperitoneal shunt who on 07-MAR-2007 was vaccinated with Pneumovax 23. Concomitant therapy included LIPITOR, ARICEPT, NAMENDA, unspecified therapy ("Unithroid") and ZOLOFT. On 08-MAR-2007 the patient experienced injection site pain, warmth, blotchiness, redness, and it was reported his arm is 1.5 inches bigger around the elbow than normal. It was reported that the patient was not feeling physically well on 08-MAR-2007 but started to feel more "like himself" on 09-MAR-2007. The patient sought unspecified medical attention. At the time of this report the patient's symptoms had not resolved. Additional information has been requested.
constant pain.; locked my arm/shoulder; This case was reported by a consumer via media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain and mobility decreased. The patient was treated with steroid shot (nos). On an unknown date, the outcome of the pain and mobility decreased were not recovered/not resolved.   It was unknown if the reporter considered the pain and mobility decreased to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient himself/ herself. The age at vaccination was not reported. The patient had the vaccine and it had locked arm/shoulder for 7 months. The patient had constant pain. The patient had a steroid shot and it relieved the pain for about a month but again had a pain. The shot has worn off.
Patient received KINRIX vaccine on right deltoid. Patient came back to office due to red, swelling (R) deltoid. Patient is being treated with KEFLEX twice a day for 10 days and needs to return to office in 2 weeks 4/30/2013 for follow-up.
h/a began 31OCt;vomited x 4, fever 102;2NOV vomited multiple times in the morning;OK by afternoon;some fever;no vomiting;
Pfizer on 3/10 and 3/31. Positive on 9/9
Myalgia, Fever, CoughWheeze, EAR ACHE Narrative:  Other Relevant History:
I had  entire right side tingling that was worse in my extremities, extreme fatigue, light fever, achy.
This spontaneous report was received from a register nurse, refers to an unspecified number of patients, of unknown age and gender. The patient's medical history and concurrent conditions were not reported. The register nurse informed that on an unknown date, the patients were vaccinated with improperly stored doses of VAQTA lot # K015827, expiration date: 11-MAR-2017; lot # L002717, expiration date: 02-JUN-2017; lot # L023936, expiration date: 15-MAR-2017 (strength, dosage and route were not reported). Concomitant therapy was not reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
History of chronic migraine, completely stable at the time of vaccination (no migraine x 3 months). Severe migraine started a few days after the first dose of the Moderna vaccine. This migraine was different in severity and quality than my typical migraines. It was VERY severe (average 8/10) and didn't subside for six weeks (daily, severe, intractable migraine), at which time I was two weeks post second dose. At that time,  it started to subside and respond to treatment and about three weeks after the second dose it went away completely. I was seen my neurologist's office and the emergency room multiple times for migraine infusions and developed Cushing's syndrome as a result of the multiple high doses of steroids I required to treat the migraine. My primary care doctor attributed this 6-week string of very severe migraines to the vaccine.
patient claimed feeling exhausted after the vaccination, reported difficulty breathing and heart rate ranging from 43-50/min. EMS was contacted. BP 90/67 HR 44 T 36.7 RR 23.  SPO2 is 100 percent. patient went stable after nursing interventions,  informed employee and EMS response request  can be cancelled if patient stable.
head ache, body ache, fever, sweaty, diarrhea, pain at injection site
Pt. received prevnar 13 immunization and came back 5 days later stating arm hurt and was very red. She treated with tylenol and benadryl. She spoke to her physician who called in ABX incase it was infected
Started with headache that evening. Took Tylenol and went to bed at 10:30 pm. Woke up at 2am with severe body aches from shoulders down. Had a temp of 100.9. Continued to have body aches for 24 hours. Tylenol was taken Q 4 durning this period. No temp recorded, body chills and extreme sweating was noted. By 01/29 I felt weak, body aches improved, no temp. By 1/30, all symptoms had ended. One episode of dizziness happened the morning of 1/30
Fatigue, chills, fever, body aches, nausea.  Lasted approximately 12 hours.  Treated with advil, fluids, and rest.  Onset of body aches and fever for second time about 36 hours after injection.  Treated with advil.
This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (I have red in my arm), PRURITUS (It itches) and PAIN (It sores) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination. No Medical History information was reported. On 25-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jul-2021, the patient experienced ERYTHEMA (I have red in my arm), PRURITUS (It itches) and PAIN (It sores). The patient was treated with HISTAMINE for Adverse event, at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Adverse event, at a dose of 10 mg. At the time of the report, ERYTHEMA (I have red in my arm), PRURITUS (It itches) and PAIN (It sores) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported.
1st shot on 5 Jun-2018, 2nd dose not yet administered; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (the patient received the first dose on 5th June 2018).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 22-JUN-2022 Reporter's Comments: The reporter gave consent to follow up. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination This case had been linked with US2019117629, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2019117629:Same reporter
Patients brother called stating patient's whole body was itching, and she was coughing.  He was instructed to have Benadryl on hand, and asked if she was having difficulty breathing.  Brother stated the coughing was making it difficult for her to breath.  He was then instructed to take the patient to the ER if she was having difficulty breathing.  Patient was called the following morning.
Patient received Moderna booster on 11/4/2021. On 11/7/2021 patient went to doctor and diagnosed with shingles.
UPPER LT THiGH SWELLing From INGUINAL CREVISE to KNEE.
Dizziness, Headache, Myalgia, Fever, c/o left ear achy,neck tight,chills,fatigue,injection site sore. Told to follow up with primary care physician if promblems persist Narrative:
Narrative:  79 year old male, received first dose of COVID-19 vaccine (Pfizer) on 3/19/2021. PMH of CAD (x4 stents), Gout, HTN, HLD. Patient expired 3/21/2021.
their arm hurt; it was more sore than ever had with any vaccine; Itching was behind their ears,Itching was in the chest,it was not extensive it was just a little line across their chest; slight allergic reaction; small itchy patch hot of hives; small itchy patch hot of hives; This spontaneous case was reported by a physician and describes the occurrence of HYPERSENSITIVITY (slight allergic reaction), PRURITUS (small itchy patch hot of hives), URTICARIA (small itchy patch hot of hives), PAIN IN EXTREMITY (their arm hurt) and PRURITUS (Itching was behind their ears,Itching was in the chest,it was not extensive it was just a little line across their chest) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included ATORVASTATIN for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced HYPERSENSITIVITY (slight allergic reaction), PRURITUS (small itchy patch hot of hives), URTICARIA (small itchy patch hot of hives) and PRURITUS (Itching was behind their ears,Itching was in the chest,it was not extensive it was just a little line across their chest). On 16-Jan-2021, the patient experienced PAIN IN EXTREMITY (their arm hurt) and VACCINATION SITE PAIN (it was more sore than ever had with any vaccine). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency. On 17-Jan-2021, PAIN IN EXTREMITY (their arm hurt) and VACCINATION SITE PAIN (it was more sore than ever had with any vaccine) had resolved. On 18-Jan-2021, HYPERSENSITIVITY (slight allergic reaction), PRURITUS (small itchy patch hot of hives), URTICARIA (small itchy patch hot of hives) and PRURITUS (Itching was behind their ears,Itching was in the chest,it was not extensive it was just a little line across their chest) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.